Skylark Bio, Inc. — Form D/A
Skylark Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2023-08-14. The offering totals $34.9M, of which $22.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-14
- Form: D/A
- Accession: 0001942495-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $34.9M
- Amount sold: $22.9M
- Remaining: $12.0M
- Investors: 2
- Date of first sale: 2022-08-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456066
Issuer
- Name: Skylark Bio, Inc.
- CIK: 0001942495
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 325 VASSAR STREET, CAMBRIDGE, MA, 02139
- Phone: 617-526-6000
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Steve Gillis | Director | New York, NY |
| Steve A Gillis | Director | Cambridge, MA |
| Giampiero A De Luca | Director | Cambridge, MA |
| Jodi A Cook | Director | Cambridge, MA |
| Jodi A Cook | Executive Officer | Cambridge, MA |
| Will A McLean | Executive Officer | Cambridge, MA |
| Nilay Thakar | Director | Cambridge, MA |
| Nilay Thakar | Executive Officer | Cambridge, MA |
| Giampiero De Luca | Director | Cambridge, MA |
Other filings by this issuer (2)
More